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 ABSTRACT 
 
INTRODUCTION Hypertension is one of the leading life style diseases and a main contributor of 
morbidity and mortality in many countries including South Africa. Standard Treatment Guidelines 
(STGs) are issued in this country to assist health care workers (HCWs) in the diagnosis and 
management of common conditions across all levels of care. The STGs include an Essential Drug List 
(EDL) as supported by WHO Bamako Initiatives (1980) for developing countries. Health systems, 
patient and physician related factors have been identified as the factors preventing blood pressure (BP) 
control in patients. OBJECTIVES Considering the debilitating effects caused by hypertension, the 
objectives were to find out if HCWs diagnose and manage hypertension correctly in terms of 
compliance to the guidelines. Guidelines are developed from credible evidence based research and are 
summarized for ease of use by HCWs. Most of the available studies on adherence to guidelines are 
self-reported and this research seeks to do a record analysis which is different from previous studies. 
METHOD 21 files of patients diagnosed between April 2009 and March 2011 with 475 documented 
visits spreading between 2009 and 2014 were purposefully selected from a sample of representative 
clinics and the hospital in the Potchefstroom sub district. A retrospective cross sectional study was 
performed using a validated data collection tool. The study included all adults above 18years of age 
and excluded all patients with co-morbidity at the time of diagnosis. RESULTS The total number of 
475 entries represented 21 patients. The majority were males (57%), with a mean age of all patients of 
52.81years. The mean systolic BP was 138.48mmHg and diastolic BP was 83.10mmHg. Compliance 
to diagnosis based on the clinical guideline, was 56% and 75% by nurses and doctors respectively with 
an overall compliance of 58%. Nurses also did not do well in terms of compliance to drug management 
at 63.5% with an overall compliance of 62.7%. There was an overall poor compliance to non drug 
management, where there was no record of health education in 55.8% of patients. CONCLUSIONS 
This study highlighted the significance of continuous professional development in terms of emphasis 
on international standards of diagnosis and non drug management. Drug management conforms to 
international trends of multiple drugs for better management of HPT. However, the generalization and 
transferability of results is compromised by the limited number of the sample size in the study. Source 
documents need to be properly monitored and information verified. Peer review of data and 
management oversight is encouraged. The use of a standard chronic form assisted in the management 
of patients by simplifying collection and documentation of clinical information over a 12 month 
period. 
_______________________________________________________________________________ 
KEYWORDS: Compliance, guidelines, guideline compliance, hypertension, health care workers 
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 CHAPTER 1 
Introduction 
The World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF) 
introduced the Bamako Initiative (BI) in the late 1980s with the purpose of improving accessibility to 
essential medicine for the most vulnerable in society to improve their health.
1
 The BI came two years 
after the Alma-Ata declaration on Primary Health Care (1978) which emphasized provision of 
essential medicines in one of its declaration. South Africa (SA) adopted a National Drug Policy (NDP) 
in 1996 after the dawn of democracy which incorporates the essential drug list (EDL) concept within 
the Essential Drugs Programme (EDP).
2, 3
  
 
The main purpose of this policy was to promote rational drug use, minimise drug costs and standardize 
supply chain management of essential medicines and the use of drugs through provisions of different 
editions of Primary Health Care (PHC), hospital adult and paediatric Standard Treatment Guidelines 
(STGs). It defined Essential medicines as “those that satisfy the priority health needs of the population 
with it being a national responsibility to identify medicines which are ‘essential’, with selection thereof 
being dependent on disease prevalence, evidence of efficacy and safety and comparative cost-
effectiveness.”2, 3 Anti hypertensive drugs that are included in most of the hypertensive guidelines 
form part of the EDL. 
 
Regrettably 20 years after the BI, the health indicators of most African countries recorded no 
significant improvement in the health status registered in such countries
1
 but according to the South 
Africa Demographic and Health Survey (SADHS) conducted in 1998 and quoted in 2003 with the 
launch of the 3
rd
 EDL there was evidence of an availability of 86% of EDL drugs and that 90% of 
medicines prescribed were on the EDL
4
 signifying a better performance by South Africa. “Essential 
medicines are intended to be available within the context of functioning health systems at all times in 
adequate quantities, in the appropriate dosage forms, with assured quality and adequate information, 
and at a price the individual and the community can afford.” 2, 5  
 
According to the Global Burden of disease study (GBD) in 2010, of 52.8 million deaths, 34.5 million 
(65%) were directly linked to non communicable disease (NCD). There has been an eleven percent 
increase of disability-adjusted life years worldwide due to NCDs between 1990 (43%) and 2010 
(54%).
6
 In South Africa there are currently 30.4% of the adult population with HPT which require the 
need for a simple approach to assessment and treatment.
7
 
 
 
1 
 
 Given the disturbing statistics associated with NCDs which include hypertension as the main disease 
and how several community-based surveys in South Africa have found that diagnosis of hypertension 
and its treatment are suboptimal 
4
, and the review of the progress since the adoption of the 1980 BI and 
1996 NDP, it was decided by the researcher to assess if HCWs in the Potchefstroom sub district North 
West province comply with the STGs in the diagnosis and management of hypertensive management. 
 
Potchefstroom sub-district is one of the four sub districts in the Dr Kenneth Kaunda district in the 
North West province with a population of 162 759 (79965 males and 82794 females) which represents 
23.38% of people in the district and 4.63% in the province according to the 2011 SA Census. The vast 
majority of these are Tswana and Afrikaans speaking.
8
 These patients are served by 9 fixed public 
health facilities (Community Health centers (CHC) =2 and Clinics=7) and two mobile clinics with the 
headcounts for the period of study shown in table 1. 
 
Health facility Type/category Headcounts Percentage  
Boikie Tlhapi CHC 111600 19 
Promosa CHC 84635 14 
Lesego Clinic 53094 9 
Mohadin  Clinic 61615 10 
Boskop Clinic 9034 2 
Gateway Clinic 46083 8 
Potchefstroom  Clinic 103628 18 
ST Clinic 57243 10 
TC Clinic 51738 9 
TOTAL  578670 100 
 
Table 1:  Headcounts for Potchefstroom health facilities for April 2010 to March 2012. 
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 CHAPTER 2 
 
Literature Review 
 
A literature search using MEDLINE from 2000 to 2011 was conducted by combining the terms 
“guideline”, “compliance”, “guideline compliance” and “hypertension.” Titles and abstracts of English 
articles were reviewed for inclusion and copies of studies that reported on prescribing patterns either 
by physicians self reported and/or research articles to guideline recommendations were included. 
References of the chosen bibliographies were screened for additional citations. Most of the articles that 
were included used guidelines on the management on hypertension from the Joint National Committee 
(JNC) to assess compliance. 
 
According to the 2003 SADHS the prevalence of hypertension (HPT) for both males and females was 
40% and 51% respectively and remained similar in 1998. The survey have demonstrated that obesity, 
high salt and alcohol intake are high in hypertensive patients, and that there is a growing need to 
implement national policy intended at promoting a healthy lifestyle and the national guidelines to 
guide in the  management of  HPT in primary health care facilities.
4 
 
Evidence based medicine is at the forefront of safe medicine practice. Major clinical research work is 
summarized in the form of guidelines for ease of use by practitioners who are too busy to confirm the 
most recent information from these trials. Most practitioners are not aware of these guidelines and 
some are aware of them but fail to follow them by choosing agents inconsistent with the national 
guideline recommendation.
 9
 General practitioners (GPs) accept an elevated BP among their clients 
contrary to the targets set by international guidelines.  
 
Hypertension (HPT) is diagnosed as elevated systolic and diastolic blood pressure of 140 and 
90mmHg respectively on three separate occasions.
4, 5, 8
 The overall prevalence in the global adult 
population in 2000 was 972 million whereas 1.56 billion are projected to have developed this condition 
by 2025.
6
 
 
BP across Europe remains poorly controlled with less than 50% of patients achieving control.  
There are three broad categories of barriers in clinical practice that can prevent patients from attaining 
BP control, namely the health system, patient related and physician related factors. The latter are 
clinical inertia, poor communication and lack of awareness/ knowledge of treatment guidelines.
 9
 
 
 
 
3 
 According to published data of Hyman and Pavlik a significant number of physicians were resistant to 
starting anti hypertensive medication where BP was not elevated above 160/95, which was in sharp 
contrast to the recommendations of the JNC-V (140/90).
 10 
 
Importance of evidence based clinical guidelines.  
Current practice of medicine relied heavily on evidence-based medicine. Guidelines highlight current 
literature and new evidence, and they create an easy step-wise approach to the management of 
diseases, the target for disease control and the standards of care.
11
  “It refers to the integration of 
information from rigorous scientific research into patient management decisions.” 12 Medical 
guidelines are considered important tools in clinical medicine and their recognition by the attending 
physicians is complex and demanding.
 10
 Debates in the treatment of elevated blood pressure and the 
validity of JNC drug recommendations are based in questions of the quality of evidence clinical 
trials.
10
 
 
The National Heart, Lung and Blood Institute (NHLBI) has administered the National Blood Pressure 
Education Program (NHBPEP) Coordinating committee over the past three decades, with one 
important function of issuing guidelines, advice, increase awareness on prevention, treatment and 
control of hypertension.
13
 Hypertension guidelines originated as far back as 1977 with regular 
 updates. 
10, 13
 This has resulted in age-adjusted mortality decline of 70% and by 80% stroke.
11 
 
According to the “The Sixth Report on the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC 6),” guidelines are developed based on latest 
evidence from observational studies and clinical trials.
14
 
 
The 1999 World Health Organization-International Society of Hypertension (WHO-ISH) guidelines 
are based on the collective expert interpretation by the guideline sub-committee of the available 
evidence from epidemiological studies and from clinical trials.
 
 
 
The value of the above is evident in the following, the 2011 UN political declaration on NCDs to 
achieve the goal of 25% reduction in premature NCD mortality by 2025 (the 25 by 25 goal) 
recommends a stepwise approach to clinical management of people at high risk of cardiovascular 
disease, including changes to health-care delivery such as shifting of tasks to middle-level health 
workers when appropriate. South Africa has since introduced clinical associates in this category as 
well as provision of fixed-dose combinations of drugs for the prevention of cardiovascular disease.
6
 
Most of the guidelines developed are for nurse driven management of non communicable diseases. 
 
4 
  
Literature in South Africa shows that EDL / Standard Treatment Guidelines (STG) enabled nurses to 
control clinical conditions of 68% of patients with HPT, 82% with non insulin dependent diabetes 
mellitus and 84% with asthma. This management of chronic diseases by nurses removed the burden of 
79% of these patients from district hospitals to the clinics and improved patient adherence from 79% to 
87%.
15
  
 
Awareness and attitude of HCWs to hypertension management guidelines. 
The compliance of the physician with guidelines seems to be influenced by knowledge and guideline 
awareness and by the time span of working in private. Awareness of guidelines dropped significantly 
between physicians who were in practice for 2 years (33.3%) and those who were in practice for more 
than 20 years (19.5%) 
10 
as a demonstration of how significant the duration of practitioners’ experience 
in practice is and their inverse use of evidence based guidelines. It was found that GPs are aware of 
their HPT guidelines but seem not to be sure that they need to follow them in practice.
 9, 10
 Forty one 
percent of doctors in the United States of America (USA) who treat patients with HPT neither heard of 
the JNC-V guidelines nor were familiar with the contents and some reported limited familiarity with 
the consensus JNC-V guidelines.
11
 An even poorer outcome is found in a German study done in 
December 1999 to March 2000, where only 23.7% of physicians where adequately aware of 
guidelines. 
10 
 
Following the review of most commonly prescribed antihypertensive drug classes Nelson and Knapp 
made an observation that prescribing patterns were in line with guideline recommendations though 
most physicians would use first-line drugs inconsistent with the national guideline recommendations, 
for example they complied with drug classes e.g. diuretics but prescribed a diuretic not recommended 
by guidelines.
 16
 The researcher’s observation for the above non compliance is that it is more often due 
to system errors where a recommended drug is out of stock and an alternative needs to be dispensed. 
 
The general belief among GPs in the United States of America (USA) appears to be that slightly 
elevated BP in the elderly is normal.
9
 In the Supporting Hypertension Awareness and Research 
Europe-wide survey (SHARE), the majority of physicians (±82%) thought that the 2007 European 
Society of Hypertension (ESH)-European Society of Cardiologist (ESC) guideline-recommended BP 
target of less than 140/90mmHg for general hypertensive patients was ‘about right’ or ‘not tight 
enough’ although a minority (19%) were satisfied if the SBP exceeded 140mmHg and 7% were 
satisfied if the DBP exceeded 90mmHg.
9
  
 
5 
 More than one third of physicians in this study were reluctant to initiate treatment in young adults or 
older adults without diabetes unless the DBP was persistently ≥ 95mmHg.9 
 
According to the primary care physician survey in the USA, physicians accepted BP that exceeded the  
goals recommended by the JNC treatment guidelines in their patients.
9
 Overall, physicians said that on 
average, 52.6% of their patients were attaining ESH-ESC recommended targets and three-quarters 
(77.4%) of physicians said that it was a challenge to get their patients to achieve these targets in 
practice.
 9, 10
 In SA in Kwazulu-Natal it was shown that when physicians fail to prescribe lifestyle 
modifications, adequate antihypertensive drug doses, or appropriate drug combinations, inadequate BP 
control may result.
3 
 
 
Why a choice of hypertension as a condition to assess compliance and not other conditions? 
 
It is easy to diagnose hypertension based on the 1995 World Health Organization (WHO)-International 
Society of Hypertension (ISH) definition of persistently elevated SBP > 140mmHg and DBP > 
90mmHg 
17
 thereby creating a universally agreed standard. Population surveys have shown that HPT is 
poorly undiagnosed or inadequately controlled 
3, 16, 17
 in around 70-75% of patients worldwide
  18
 when 
it’s easier to diagnosis and treat than other chronic conditions that require the collection of blood 
samples or other expensive technical measures.
10
 
 
Developed countries have the greatest estimated number of people with HPT 
19
 with 35 million office 
visits in the US with HPT as the primary diagnosis.
11, 13
 HPT affects approximately 1 billion 
individuals worldwide and the prevalence increases with increasing age.
13, 16 
It is a common chronic 
disease that serves as the measure of the effectiveness of public health education, professional 
education and health care system in the country. 
11
 
 
According to the Global burden of HPT in 2000, sub-Saharan Africa which included SA, hypertension 
accounted for 23.9% of the overall prevalence
 19
 and the 1988 SADHS showed a 20% prevalence then 
and the 2003 SADHS figures stand at 40% and 51% for men and women respectively.
4  
It is evident 
that mortality and morbidity from heart diseases are increasing so rapidly 
7, 13
 in developing countries 
that they will rank number 1 and 4 respectively as causes of the global burden of disease by the year 
2020,
14
 noting that hypertension is the leading cause of cardiovascular diseases and its complications 
account for the top three causes of death in SA.
7
 The ultimate public health goal of antihypertensive 
therapy is the reduction of cardiovascular and renal morbidity and mortality. 
 
6 
 
  
There is correlation between overweight and obesity which contribute to the increase in BP and related 
conditions. That there are 122 million people with the above life style risk factors the risk of 
developing hypertension is inevitable. There is a move towards reducing sodium in the food by 51% in 
the next coming decade.
 13
 Cardiovascular diseases (CVD) account for 30% of global mortality with 
HPT being the more frequent modifiable risk factor for cardiac and renal disease.
 19
 The risk of 
elevated BP is continuous, consistent, independent of other risk factors and directly proportional to 
heart attack, heart failure, stroke and kidney disease.
 4, 13, 17
 
 
 “It is a well documented knowledge that achieving normotensive in hypertensive patients can 
significantly reduce the risk of cardiovascular morbidity and mortality with more intense BP control 
providing greater risk reduction.” 7, 8, 10 
 
Screening, case finding and early and sufficient management of HPT improves patient prognosis and 
may contribute to cost containment for health care providers.
10
 Current studies (Hypertension Optimal 
Treatment (HOT), Systolic Hypertension in the Elderly Program (SHEP) and Swedish Trial in Old 
Patients with Hypertension (STOP-Hypertension) have impressively shown that efficient 
antihypertensive therapy will decrease the incidence of stroke and cardiac events by up to 51%. 
10 
 
 
“The burden of undiagnosed and sub optimally treated hypertension on the health of people is a major 
contributor to the prevalence of adult diseases in any population and this can be avoided if early 
detection and cost-effective management of the condition occurs”.4 Complications of uncontrolled 
hypertension that contribute to this burden of diseases are cerebrovascular, renal and cardiovascular 
diseases which could predispose to congestive heart failure.
4, 13, 17
 
 
The management of hypertension provides a barometer to assess physicians’ awareness of medical 
guidelines and compliance on the background of its prevalence and the significant economic burden of 
this disease and the numerous guidelines that existed for many years.
6, 10 
 
All the above point to the importance and influence of hypertension as a major NCD, its outcomes to 
individuals if poorly managed and the overall negative global health impact. This all contributed 
towards the choice of this condition in particular to be studied. 
 
 
 
7 
 Research focus. 
 
Practical guidelines are important tools for clinical decision making. They are used to reduce practice 
variation, guide appropriateness and measure the quality of care.
16
 Research has shown a large number 
of primary care physicians underestimate a target BP <140/90 as recommended by the JNC guidelines, 
thereby not intensifying BP control to achieve a target below 140/90. 
10
 BP control among European 
hypertensive patients remain sub-optimal with <50% achieving BP goal.
8
 Many self reported studies 
have come to the conclusion that physician adherence to hypertension guidelines is low.
 9, 10, 16, 18
 
 
The SHARE survey concluded that clinical inertia is putting patients at increased cardiovascular risk 
and contributing to the substantial health and economic burden associated with uncontrolled BP. A 
number of studies indicate that in most populations studied, a moderate proportion of all hypertensive 
patients are untreated and a large proportion of treated hypertensive patients still have frankly elevated 
blood pressures, defined most frequently as SBP >160 or DBP >95mmHg. 
9, 10, 11, 16, 18 
 
 
In South Africa most of the guidelines are developed for nurse driven management of non 
communicable diseases and some national data have shown poor adherence by physicians to 
guidelines.
16,  20  
 
Despite the release of 7 treatment guideline on hypertension by the National Heart, Lung, and Blood 
Institute (NHLBI), treatment goal remains suboptimal at 66% in the USA and where approximately 20 
million remain untreated. 
15
 Doctor patient effective communication lies at the core of the successful 
management of HPT and failure to establish and maintain it will generally lead to poor adherence to 
antihypertensive therapy and unsatisfactory control of the raised BP.
 3, 15 
 
Adherence studies that use medical record data critically assume that documentation in medical 
records accurately reflect practice.
9, 10, 11, 16, 20
 “Although this assumption is reasonable, the adequacy 
of physician documentation could vary across physicians and across studies. Indeed, the differing 
conclusions in these studies might reflect variation in the adequacy of physician documentation as well 
as actual variation in adherence. Because none of the studies that were reviewed demonstrated a close 
relation between documentation and practice, their conclusions regarding adherence remain 
tentative.”16 
 
 
 
 
 
8 
 Most of the surveys 
9, 10, 12, 16
 found were done by self administered questionnaires which may reflect 
bias. The researcher decided to conduct a chart review to verify self reporting and attempt to identify 
the real practice situation. 
 
The researcher’s hypothesis was that health care workers do not comply with HPT treatment 
guidelines to achieve BP control and it was decided to conduct research within Potchefstroom primary 
health care sub-district 
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 CHAPTER 3 
Aim 
• To assess the degree of compliance of HCWs to STGs in the management of hypertensive 
patients in Potchefstroom sub-district primary health care (PHC). 
Objectives 
• To describe the demography of newly diagnosed patients with hypertension at Potchefstroom 
sub-district for the years 2009 to 2011. 
• To assess compliance to STG in terms of hypertension diagnosis; and 
• To assess compliance to management (drug and non-drug) of newly-hypertensive patients 
diagnosed within the study period.  
 
Methodology  
 
Study design:  Purposeful retrospective sampling was conducted for the period of April 2009 to 
March 2011 of newly diagnosed hypertensive patients above 18years old from nine fixed health 
facilities. 
Study population:  All hypertensive patients diagnosed between April 2009 and March 2011 who 
were above 18 years without co-morbidity of chronic conditions like diabetes mellitus, epilepsy, 
asthma, tuberculosis and Human Immunodeficiency Virus (HIV) at the time of diagnosis were 
included. According to the District Health Information System (DHIS) (Annexure A1) for the period 
of the study, there were 1710 new cases of hypertension and the researcher’s initial study sample was 
set at 150 files representing 10% of the population with 4 clinic visits over a 12 month period. 
New HPT cases in Potchefstroom sub-district according to DHIS April 2010 to March 2012 
1710 (Annexure A1) 
 
Study target of 10% from 1710  ≈ 150 files 
 
New HPT cases according to individual clinic data from DHIS was 1519 (Annexure A2)  
This was less than the total in Annexure A1, therefore a discrepancy 
 
Revised study target of 10% from 1519 = 151 ≈ 150 
 
Screening of patients who were meeting the criteria for inclusion in the study at all clinics  
 
Retrieving files of selected patients, most of whom did not meet the criteria 
   
21 Files that met the criteria were selected 
 
Compensation was made by including more visits per patient the total visits were 475 
10 
 Sampling: A screening tool for selection (Annexure B) with emphasis on the period of diagnosis, and 
exclusion of co morbidities of diabetes, epilepsy, asthma and tuberculosis, patients younger than 18 
years, pregnancy and exclusion of the area of diagnosis outside Potchefstroom was developed for the 
study. It was introduced and discussed with facility health care workers to identify eligible candidates. 
All the patients who fit the inclusion criteria at each clinic were sampled. The response was 
encouraging initially but after getting the files most of the patients did not meet the criteria especially 
with regard to period of diagnosis. A new approach was implemented to get patients’ health passport/ 
clinic health books which could confirm the period of diagnosis. As a result the sample size of initially 
identified patients dropped significantly. Thus another strategy was to access the local hospital records.  
 
Two boxes of health passports or clinic health books of patients attending Potchefstroom regional 
hospital as well as the sub district clinics were collected from the admission department and screened 
for clients that could meet the research criteria and those that met the standards were included in the 
study. According to the WHO- How to investigate drug use in health facilities, “in drawing a 
retrospective sample of patient encounters, the basic indicator study calls for a sample of 30 
prescribing encounters per health facility, or 100 encounters if prescribing practices in individual 
facilities are to be compared”.21 Due to strict inclusion criteria which pre-suppose a relatively low 
yield of patients, it was decided based on the above WHO report to concentrate on encounters rather 
than patients for sample size and strength.  
 
Inclusion and exclusion criteria: The study included all adults above 18years of age who had been 
diagnosed during the study period and excluded all patients with co-morbidity at the time of diagnosis. 
Due to the limited number of patients at primary health care, who qualified using the criteria, the files 
of patients diagnosed at clinics were also accessed at the hospital and included.  
 
Data collection: A clinically orientated data collection tool (Annexure C) was developed in line with 
the STG in terms of diagnosis, drug and non drug management. This was validated by a statistician at 
North West University and data was manually retrieved from the patients’ clinical records in all health 
facilities. Variables included in the tools were the demography of the patients (Clinic registration 
number, research number based on first 2 letters of the clinic, age, gender), BMI, BP levels at 
diagnosis and follow up, evidence of target organ damage in terms of proteinuria and haematuria as the 
only available indicators to be assessed, compliance to drug and non drug management and the 
category of health care worker involved. This information was sourced from the clinic chronic 
management form.  
 
 
11 
 Diagnosis of HPT is based on three readings hours or days apart and the target BP was 140/90mmHg 
for patients without co morbidities. The 2008 PHC standard treatment guidelines and essential 
medicines list was used as the reference for assessing diagnosis and management in this study. 
Management was classified according to the steps illustrated in Table 1 and in line with international 
standards. 
 
STEPS INTERVENTION 
Stat Amlodipine for HPT emergency BP >180/130 or HPT Urgency BP >240/140 
1 Life style modification only 
2 Life style modification and single anti hypertensive group class 
3 Life style modification and two anti hypertensive group classes 
4 Life style modification and three anti hypertensive group classes 
5 Life style modification and four anti hypertensive group classes 
 
Table 1 Hypertensive management steps. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12 
 
 Ethics 
 
The study received ethical clearance from the Witwatersrand University Human Research Ethics 
Committee clearance number M130265 22 February 2013 (Annexure D) and the North West 
Department of Health Policy, Planning, Research, Monitoring and Evaluation (NWPPRME) in July 
2013 (Annexure E). In order to maintain patient confidentiality only registration numbers were used. 
Consent form was not used as there was no direct communication with patients.  
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 CHAPTER 4 
Results 
All values are expressed as mean and standard deviation (±SD) except where stated. 
Twenty one (21) files were selected from a representative sample of sub district PHC facilities. The 
majority of the patients came from health centres comprising 61.90% of the total sample. This 
represented 50% of the sub-district clinics. Three copies of primary health care books were also traced 
to the local hospital. See table 2. The researcher would have liked to obtain samples from each of the 
clinics but given a great amount of logistical challenges experienced only settled for the clinics 
indicated above.  
 
Table 2 shows the number of encounters per facilities being above 30 which met 80% of WHO 
standard on how to investigate drug use in health facilities. 
FACILITY FILES Number of encounter 
Boiki Tlhapi CHC 7 132 
Promosa CHC 6 170 
Lesego clinic 3 74 
Mohadin clinic 2 37 
Hospital files 3 22 
 
Table 2: Facility prescribing encounters.  
 
The age for the sample ranged between 31 to 85 years with an overall sample average of 52.81 years. 
See table 3. The sample was composed of 57% male and 42% female patients. See table 4. Age was 
adjusted at every birthday during follow up visits.   
  N Minimum Maximum Mean Std. Deviation 
p Value according to 
Kruskal-Wallis test: 
Age 21 31 85 52.81 15.864 .6105 
 
Table 3. Age 
 
 Frequency  Percentage 
Female 9 43 
Male  12 57 
Total  21 100 
 
Table 4. Gender 
BMI ranges from normal to severely obese with a mean average of 28kg/m
2
 which is normal according 
to what classification. See table 5. It is encouraging to see BMI done as part of patient management 
considering the direct relationship there is between obesity and cardiovascular risk.
 22
 Regrettably 42% 
of the BMI’s were not calculated due to lack of weight/height or both for sample. 
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 Of the calculated BMI’s 23% were obese whereas overweight and normal weights accounted for 14% 
each.  
 
There was no significant difference between different clinics in terms on height, weight and body mass 
index using the Krusmal-Wallis test which is used to calculate the p-Value. The non-parametric test is 
used due to a small sample size as it is difficult to test the assumption of normality due to lack of 
power. See table 5a and 5b below.  
 
Clinic   N Minimum Maximum Mean Std. Deviation 
Boiki  AVE BMI 5 26 36 31.00 3.606 
Tlhapi AVE Ht 5 149 170 161.00 7.583 
 AVE WT 7 72 86 78.14 5.014 
       
Lesego AVE BMI 2 22 25 23.50 2.121 
 AVE Ht 2 161 165 163.00 2.828 
 AVE WT 3 51 81 66.33 15.011 
       
Mohadin AVE BMI 1 25 25 25.00   
 AVE Ht 1 163 163 163.00   
 AVE WT 2 66 67 66.50 .707 
       
Hospital AVE BMI 1 18 18 18.00   
 AVE Ht 1 172 172 172.00   
 AVE WT 2 55 64 59.50 6.364 
       
Promosa AVE BMI 3 27 37 33.67 5.774 
 AVE Ht 3 151 165 156.33 7.572 
 AVE WT 6 65 145 91.50 29.670 
Table 5a. Mean BMI at each clinic 
 
Average N Minimum Maximum Mean Std. Dev p Value according to Kruskal-Wallis 
test: difference between clinics 
Weight 20 51 145 77.35 19.850 .0998 
Height 12 149 172 161.25 7.073 .5228 
BMI 12 18 37 28.83 6.073 .0844 
Table 5b. Mean BMI at all clinics 
 
The Krusmal-Wallis test has been used again to calculate the p-Value due to a small sample size as it 
is difficult to test the assumption of normality due to lack of power hence the lack of significant 
difference between SBP and DBP at diagnosis at different clinics. See table 6a and 6b below. 
Clinic  Variable Valid N Minimum Maximum Mean Std. Dev 
Boikie  Initial SBP 132 70.0000 200.0000 137.5639 17.73224 
Tlhapi Initial BP 132 44.0000 134.0000 80.5890 13.38759 
       
Lesego Initial SBP 75 100.0000 180.0000 136.6267 18.68644 
 Initial BP 75 49.0000 149.0000 72.5600 15.93589 
       
Mohadin Initial SBP 39 110.0000 190.0000 146.6923 21.21836 
 Initial BP 39 51.0000 118.0000 84.5385 15.26580 
       
Hospital Initial SBP 24 110.0000 162.0000 136.7917 12.98822 
 Initial BP 24 70.0000 101.0000 85.0833 8.38693 
       
Promosa Initial SBP 168 101.0000 201.0000 138.7321 19.41740 
 Initial BP 168 55.0000 128.0000 83.3690 14.03441 
       
Final  Initial SBP 438 70.0000 201.0000 137.5639 18.90417 
Data  Initial BP 438 44.0000 149.0000 80.5890 14.58707 
Table 6a. Mean BP at each clinic 
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Average N Minimum Maximum Mean Std. Dev p Value according to Kruskal-Wallis 
test: difference between clinics 
Ave SBP 21 126 154 138.48 8.761 .8034 
Ave DBP 21 69 102 83.10 8.665 .6261 
Table 6b. Mean BP at all clinics. 
 
The ANOVA has been used in the table 7b below due to the large sample size. In this case the central 
limit theorem holds that means are normally distributed and shows significant difference between SBP 
(p=0.002876) and DBP (p=0.000000) at different clinics. 
 
Clinic  Variable Valid N Minimum Maximum Mean Std. Dev 
       
Boikie  Average SBP 7 126.0000 153.0000 136.1429 9.82223 
Tlhapi Average BP 7 75.0000 100.0000 82.1429 8.41484 
       
Lesego Average SBP 3 126.0000 147.0000 139.3333 11.59023 
 Average BP 3 69..0000 102.0000 80.6667 18.50225 
       
Mohadin Average SBP 2 137.0000 154.0000 145.5000 12.02082 
 Average BP 2 82.0000 87.0000 84.5000 3.53553 
       
Hospital Average SBP 3 132.0000 140.0000 136.6667 4.163 
 Average BP 3 81.0000 89.0000 85.3333 4.041 
       
Promosa Average SBP 6 132.0000 154.0000 139.3333 8.43010 
 Average BP 6 77.0000 96.0000 83.8333 7.75672 
       
Average Ave SBP 21 126 154 138.48 8.761 
Level  Ave DBP 21 69 102 83.10 8.665 
Table 7a. Mean BP level at follow up at each clinic 
 
 
Average N Minimum Maximum Mean Std. Dev p Value according to ANOVA: 
difference between  clinic 
Ave SBP 438 70.0000 201.0000 137.56639 18.90417 0.002876 
Ave DBP 438 44.0000 149.0000 80.59 14.587 0.000000 
Table 7b. Mean BP level at follow up at all clinics. 
 
 
Though not the focus of the study it was found that 62% of the sample had controlled BP 
(<140/90mmHg) whereas 10% and 28% had moderate and mild HPT respectively. Hypertensive 
emergency was recorded in 16 visits representing 8 patients where in only one, Amlodipine 10mg stat 
was given. BP control is invariably related to other patient factors that were not assessed in this study 
and a qualitative type of study could yield much better reasons for BP control. Table 8 below shows 
compliance in terms of diagnosis by health care workers and reflects the nature and characteristic of 
clinics where the majority of patients are seen by nurses (76%). In terms of percentages, doctors are 
seen to correctly diagnose patients at 75% compared to 56% for nurses but nurses saw many more 
patients than doctors. 
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 Compliance in terms of diagnosis by health care workers 
HCWs Encounter per HCW No(%) Yes(%) 
Unaccounted 1 1(100) 0(0) 
DRs 4 1(25) 3(75) 
PNs 16 7(44) 9(56) 
Total  21 9(42) 12(58) 
 
Table 8.  Appropriate diagnosis by health care workers of the patients that they have seen during the 
period of study. 
 
Compliance to drug management by nurses was ahead of doctors at 63.5% and 56.6% respectively as 
shown in table 9. The p-value is 0.336 indicating no statistical significant difference between 
compliance of 3 groups. Step 2 drug management had a total of 105 BP measurement qualifying visits 
and only 89 (85%) complied whereas step 3 had 212 BP measurement qualifying visits with 141(60%) 
compliance. Step 4 which relates to the use of three drugs had 62 (48%) compliance and 66(52%) non 
compliance. It seems as if there is a fine balance between compliance to the guidelines and not adding 
an additional drug which is defined as physician inertia to compliance. There was a 340 (71%) use of 
more than one drug in the management of HPT which is in line with international standards of the use 
of more than one drug for the management of BP.  
 
Compliance to drug management by health care workers 
HCWs Encounter per HCW No(%) Yes(%) 
Unaccounted 3 1 (33.3) 2 (66.7) 
DRs 45 20 (44.4) 25 (56.6) 
PNs 427 136 (31.9) 271 (63.5) 
Total  475 157 (33.1) 298 (62.7) 
 
Table 9. Compliance to drug management by health care workers 
 
Life style modification is an important aspect of patient management (Table 10) and studies have 
shown significant drop in BP according to different life style changes.
10
 Very little is said about 
tobacco use despite causing a staggering mortality rate of about 6 million lives annually and a costs of 
1 – 2% of global gross domestic product annually.3    
 
Compliance to non drug management by health care workers 
HCWs 
Unaccounted Diet Exercise HE None 
Rx 
Comp Smoking Yes 
Total 
Unaccounted 0 1 0 0 2 0 0 0 3 
DRs 0 2 0 12 27 3 1 0 45 
PNs 16 43 4 52 236 70 4 2 427 
Total (N) 16 46 4 64 265 73 5 2 475 
Total (%) 3.4% 9.7% .8% 13.5% 55.8% 15.4% 1.1% .4% 100.0% 
 
Table 10. Compliance to non drug management by health care workers 
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 CHAPTER 5 
Discussion 
Of the 21 patients selected for the study the majority were men at 57% and females were 43% (Table 
3). The general trend regarding gender is that women are usually in the majority like in the two SA 
population studies done in 1988 and 2003 and this deviation from the usual norm is probably by 
chance given the small sample size.
6
 It should be emphasized though that identifying men at risk of 
cardiovascular disease is important as men had a higher prevalence of coronary artery disease (75%) 
than women (66%) as documented in the 26-year follow up of participants in the Framingham heart 
study.
22 
 
 
Table 4 gives the demography of the sample regarding age and BMI. Of the 21 patients 20 were 
checked for their weight and only 12 checked for the height making assessment of BMI possible in 
only 57%. The mean BMI was 28 which is classified as obesity. Of the calculated BMI‘s 23% were 
obese whereas overweight and normal weights accounted for 14% each. Monitoring of the patients in 
the sub-district for the period of this study did not include waist circumference and thus could not be 
included in the assessment of obesity and for the assessment of cardio vascular risk. Noting that some 
parameters of BMI were not assessed, the use of waist circumference can be the most ideal and easy 
tool to be considered for future assessment of obesity.  
 
Cardio vascular risk assessment can only be made possible with proper assessment of predictors of risk 
including BMI. The age group reflects the category that we see in our facilities where young patients 
are usually referred to hospital due to complicated hypertension though patients below 18 years were 
excluded from this study. 
 
The mean systolic and diastolic BP at diagnosis and follow up (Table 5 and 6) of this study are higher 
than the previous two population studies done in South Africa though they cannot be compared given 
the big difference in sample size. The documented diastolic BP values of subjects in the 2003 survey 
were much lower than was recorded in 1998 resulting in almost 50% reduction of hypertensive 
prevalence when compared to 2003 survey. 
5
 In the 1998 survey, the cut off point for BP was 160/95 
and in 2003 it was 140/90 which explains why BP readings were lower in 2003 than in 1998 and this 
resulted in an increase of 6 percent of prevalence.  
 
One of the objectives was to check compliance to diagnosis and of the 4 patients that doctors saw 3 
were appropriately diagnosed making it 75% correct and nurses appropriately diagnosed 12 out of 16 
which makes it 58% (Table 7). It has to be noted that all patients will have been seen and started on 
treatment by nurses and referred to the doctor for confirmation of the diagnosis.  
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 At diagnosis a total of 9 patients which represents 42% were not diagnosed as hypertensive despite 
meeting all criteria for hypertensive diagnosis in agreement with the SHARE study that has 
demonstrated that physicians were hesitant to initiate or take action for elevated BP.
9 
In the eThekwini 
study done in KZN the mean adherence to hypertensive treatment guidelines in state facilities was 
22.05% which had a better sample representation of 2100 prescription than this study.  
 
Much as the above two studies do not compare statistically due to the large differences in their patient 
numbers,  there is a positive trend towards an increase in compliance to diagnostic guidelines by 
nurses who are the backbone of PHC  in both studies  
 
The majority of patients are seen and managed by PNs (271) with 63.5% compliance to drug 
management and 56% compliance to diagnosis. However the non drug management was not well 
documented. Professional nurses performed better in the control of BP during the follow up than they 
did at diagnosis. A safety net is created at diagnosis where newly diagnosed patients are to be seen by 
doctors to initiate them on chronic medication. This is encouraging as nurses are the people that see 
majority of chronic patients in the facilities. 
 
 
It was regrettable that overall 56% of clients were not advised on any form of non drug management 
and only 10% had documented encounters regarding diet and exercise as these are the major 
contributors toward obesity which in turn impacts on cardiovascular illness. 
 The Dietary Approaches to Stop Hypertension (DASH) study has shown a reduction of 8 – 14mmHg 
whereas weight reduction has dropped BPs by 5 – 20mmHg with a 10kg weight loss.7 Emphasis on the 
above can yield positive results in BP control.
11
  
 
There were some system errors noted in the study with urine dipstick out of stock and 60% of side 
room examination (urinalysis) was subsequently not done to rule out renal pathology. Bibliography in 
this study has shown how HPT cause high mortality and morbidity from cardiac and renal disease and 
failure to do urinalysis will impair screening of patients for related renal complications. Urinalysis is 
more convenient and less costly than laboratory investigations.    
 
Unavailability of certain drugs also influenced practice at interim periods. EDL drugs were however 
mainly prescribed as per EDL guidelines. 
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Validation of source documents is a major concern. This is illustrated at Boskop clinic which recorded 
an average of 2 newly diagnosed hypertensive cases per month during the period of study and a sudden 
spike of 96, 104 and 87 newly diagnosed patients in August 2010, November 2010 and January 2011 
respectively (Annexure A2). This is a clinic with a total head count per facility of 2% compared with 
other health facilities in the sub district (Table 1). The above numbers therefore clearly cannot be 
correct. The electronic data capturing system, e-tools,  only captures the category “HPT new patients’’ 
without a consideration for follow up patients and the suspicion is that follow up patients were 
captured under new patients instead. 
 
This data problem resulted in the overestimation of the research population and sample size. 
Achievement of the target sample size was attempted using the screening tool where most of the 
respondents did not meet the study criteria.  
 
The use of stat dose medication in a hypertension emergency in this study was not supported by 
documentation of associated unstable angina/ chest pain, neurological signs, pulmonary oedema and 
renal failure, nevertheless the appropriate EDL drug Amlodipine 10mg orally was used for severe BP. 
Of a number of the patients with HPT emergencies only one patient from Lesego clinic was referred to 
the next level of care as per the guidelines. Non hospital referral might be as a result of availability of 
doctors in the facilities which was not assessed in this study. 
 
The average compliance of self reported studies to guidelines was 23.7%.
9, 11, 20
 In this study a 
considerable higher performance was found.  
 
Limitations 
 
The small sample size of the study is the main limitation in comparison with other studies cited in this 
research though the number of clinic visits compensated for the shortfall. The sub district information 
according to the DHIS reflected a significant number of newly diagnosed patients during the study 
period and there was an expectation for a significant sample size only to identify discrepancies in the 
quality of source documents. 
 
Patients are encouraged to take their clinical records to the referral hospital but significant records 
were left/lost at the hospital. This affects continuity of care if old clinical notes are not readily 
available for HCW.   
There were instances of drug stock outs that might have affected drug treatment compliance with 
HCWs resorting to the only available medication at the time.  
20 
 The researcher would assessed HCW as being non compliant if reasons for different drug use other 
than the recommended ones in the guidelines are not used.  The other systems error noted in the study 
was stock out of urine test strips compromising the assessment of complications associated with 
uncontrolled hypertension. 
 
As this research was done by record analysis, the individual clinical reasons for different drug or drug 
class use would not have been assessed due to lack of supporting clinical notes. 
There was inconsistency in clinical examinations of patients where some parameters are assessed and 
others e.g. height and weight were not. 
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 CHAPTER 6 
Conclusions and recommendations 
 
This study highlighted the significance of keeping abreast with ever changing clinical practices based 
on new clinically proven evidence through continuous professional development in terms of an 
emphasis on international standards of diagnosis and non-drug management of hypertension. There are 
few internationally reputable organizations/ societies discussed in the study dealing exclusively with 
hypertension as their topic of interest and endorsed by WHO that we need to continuously familiarize 
ourselves with their latest trends and recommendations in the management of hypertension.  
 
Self reported studies have demonstrated how clinical inertia prevents doctors from acting on elevated 
BPs despite their awareness of guidelines.  
 
Nurses are the main service providers in PHC and it is encouraging to see the increased level of 
compliance both in diagnosis and management.  Compliance to drug management by nurses was ahead 
of doctors at 63.5% and 56.6% respectively.  
Of clinical significance was the following: of the calculated BMI’s, 23% were obese whereas 
overweight and normal weights accounted for 14% each. 
Though not the focus of the study it was found that 62% of the sample had controlled BP 
(<140/90mmHg) whereas 10% and 28% had moderate and mild HPT respectively. Hypertensive 
emergency was recorded in 16 visits representing 8 patients. 
Source documents need to be properly monitored and information verified. Peer review of data and 
management oversight is encouraged. Training of staff on the chronic patient records and/or DHIS 
record is critical for uniformity in terms of data collection. The use of a standardized chronic form 
improved management of patients by simplifying collection and documentation of clinical information 
over a 12 month period. 
 
The study did not succeed in achieving an adequate sample size to be able to generalise the results to 
the sub district under study and other sub districts in the province. 
 
There is an opportunity to do a prospective study where all newly diagnosed patients can be properly 
followed and assessed for compliance in terms of hypertension diagnosis and management. Qualitative 
study might also assist in answering the issues that are not documented with regard to health 
education.  
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 HYPERTENSIVE NEW CASES PUT ON TREATMENT IN A SUB DISTRICT 
 
Sum of EntryNumber   DataPeriod                       
SortOrder DataElement Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
Grand 
Total 
103 Hypertension case  2010       58 36 49 58 176 67 95 157 32 728 
  
put on treatment - 
new 2011 143 49 37 46 73 42 62 84 95 61 72 38 802 
    2012 56 61 63                   180 
               
1710 
 
HYPERTENSIVE NEW CASES PUT ON TREATMENT PER FACILITY 
 
nw Boskop Health Post Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       2 2 3 0 96 4 2 104 4 217 
  2011 87 0 0 0 0 2 0 0 1 0 0 0 90 
  2012 0 1 0                   1 
nw Top City Clinic Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       4 2 0 3 6 7 2 2 5 31 
  2011 6 0 3 2 1 7 2 12 2 7 5 3 50 
  2012 1 2 8                   11 
nw Boiki Thlapi CHC Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       4 0 5 5 2 0 2 1 3 22 
  2011 1 2 2 2 2 2 4 7 2 4 2 3 33 
  2012 6 2 5                   13 
nw Lesego Clinic Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       3 6 6 0 1 0 4 5 0 25 
  2011 7 5 2 2 4 0 3 3 2 2 4 2 36 
  2012 2 1 0                   3 
nw Mohadin Clinic Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       4 2 2 5 4 0 14 8 6 45 
  2011 4 3 2 2 13 4 3 0 8 12 16 7 74 
  2012 19 11 13                   43 
nw Promosa CHC Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       7 3 12 14 12 0 5 5 2 60 
  2011 3 8 5 1 13 5 13 13 8 3 1 7 80 
  2012 8 2 2                   12 
nw Potchefstroom Clinic Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       20 4 6 13 16 33 28 18 8 146 
  2011 19 14 11 18 14 11 18 31 21 13 30 3 203 
  2012 10 8 6                   24 
nw Steve Tshwete Clinic Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       10 13 1 8 31 4 5 0 4 76 
  2011 12 6 5 7 16 7 12 11 7 5 5 7 100 
  2012 3 17 18                   38 
nw Gateway Clinic Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
Hypertension case - new 2010       3 4 12 8 0 18 12 10 0 67 
  2011 1 0 0 4 3 0 1 0 2 0 1 1 13 
  2012 1 0 5                   6 
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Annexure A1 
Annexure A2 
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Annexure B 
  
 
DATA COLLECTION TOOL 
 Clinic  
Demography  
Pseudo name  
Reg no  
Sex  
Age   
 
BMI 
Weight 
 Height 
 Visit type Initial/ follow up visit 
 Date of visit Month or Annual 
 Initial BP check SBP and DBP 
 2nd BP check SBP and DBP 
 3
rd
 BP check SBP and DBP 
Diagnosis  Appropriate/ Not 
 Target BP reached Yes/ No 
Drug management  
Amlodipine 10mg Appropriate/ Not 
Hydrochlorothiazide 12.5mg Appropriate/ Not 
Hydrochlorothiazide 25mg Appropriate/ Not 
Perindopril 4mg Appropriate/ Not 
Enalapril 5mg Appropriate/ Not 
Enalapril 10mg Appropriate/ Not 
Enalapril 20mg Appropriate/ Not 
Nifedipine XL 30mg Appropriate/ Not 
Amlodipine 10mg Appropriate/ Not 
Atenolol 50mg Appropriate/ Not 
Furosemide 40mg Appropriate/ Not 
Drug management step (Table 1)  Appropriate/ Not 
 Urine test Protein 
 Blood 
 Glucose 
Non drug management (Figure 1) Life style  Appropriate/ Not 
 Hospital transfer Yes or No 
 Health care worker Nurse or Doctor 
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Annexure C 
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Annexure D 
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Annexure E 
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